4.7 Article

The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Hepatic Regulator of G Protein Signaling 5 Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Transforming Growth Factor Beta-Activated Kinase 1-c-Jun-N-Terminal Kinase/p38 Signaling

Junyong Wang et al.

Summary: The study found that RGS5 protects against NAFLD and nonalcoholic steatohepatitis, and that it is negatively associated with mitogen-activated protein kinase signaling cascades in response to metabolic challenges. RGS5 directly interacts with TAK1, inhibits its hyperphosphorylation, and prevents the activation of the downstream JNK/p38 signaling cascade.

HEPATOLOGY (2021)

Article Cell Biology

The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure

Ahmad A. Cluntun et al.

Summary: The metabolic rewiring of cardiomyocytes, including decreased mitochondrial pyruvate oxidation and increased lactate export, is a key feature of heart failure. The mitochondrial pyruvate carrier (MPC) and the cellular lactate exporter monocarboxylate transporter 4 (MCT4) play pivotal roles in this metabolic axis. Alteration of the pyruvate-lactate axis is a fundamental and early feature of cardiac hypertrophy and failure.

CELL METABOLISM (2021)

Article Cardiac & Cardiovascular Systems

Klotho Deficiency Causes Heart Aging via Impairing the Nrf2-GR Pathway

Kai Chen et al.

Summary: This study investigates the role of Klotho in cardiac aging, revealing that Klotho deficiency causes cardiac aging through impairing the Nrf2-GR pathway. Supplement of exogenous secreted Klotho represents a promising therapeutic strategy for aging-associated cardiomyopathy and heart failure.

CIRCULATION RESEARCH (2021)

Article Cardiac & Cardiovascular Systems

Oxidation of Protein Kinase A Regulatory Subunit PKARIα Protects Against Myocardial Ischemia-Reperfusion Injury by Inhibiting Lysosomal-Triggered Calcium Release

Jillian N. Simon et al.

Summary: The study revealed that PKARI alpha disulfide formation is significantly increased in response to I/R in both humans and mice, leading to enhanced AKAP binding and preferential localization to the lysosome. This redox-dependent regulation of lysosomal channels by PKARI alpha plays a critical role in protecting the heart from extensive injury and could serve as a novel target for cardioprotective therapeutics.

CIRCULATION (2021)

Article Cell Biology

Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1

Lin Wang et al.

Summary: The study identified TRIM16 as a promising therapeutic target for NASH by demonstrating its ability to alleviate lipid accumulation and inflammation in the liver, as well as suppress the activation of the MAPK signaling pathway. This suggests that TRIM16 could be a potential candidate for treating NASH-related liver disorders and hepatocellular carcinoma.

CELL METABOLISM (2021)

Review Pharmacology & Pharmacy

Nrf2 for cardiac protection: pharmacological options against oxidative stress

Qin M. Chen

Summary: This article discusses the role of Nrf2 in myocardial ischemia or reperfusion, as well as its potential as a target for drug development.

TRENDS IN PHARMACOLOGICAL SCIENCES (2021)

Article Cell Biology

Tripartite motif-containing protein 16 protects against myocardial ischemia/reperfusion injury by affecting the Keap1/Nrf2 axis

Qianwei Cui et al.

Summary: TRIM16 protects against myocardial I/R injury by affecting the Keap1/Nrf2 axis. Overexpression of TRIM16 can alleviate H/R-induced cardiomyocyte injury and reduce cardiac injury and myocardial apoptosis induced by I/R injury.

CELL AND TISSUE RESEARCH (2021)

Review Biochemistry & Molecular Biology

Nrf2: Redox and Metabolic Regulator of Stem Cell State and Function

Xiaozhen Dai et al.

TRENDS IN MOLECULAR MEDICINE (2020)

Review Biochemistry & Molecular Biology

TRIM proteins in autophagy: selective sensors in cell damage and innate immune responses

Martina Di Rienzo et al.

CELL DEATH AND DIFFERENTIATION (2020)

Review Cardiac & Cardiovascular Systems

Emerging Role of TRIM Family Proteins in Cardiovascular Disease

Jing-rui Zhang et al.

CARDIOLOGY (2020)

Article Medicine, Research & Experimental

Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis

Chaoliang Tang et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Review Cardiac & Cardiovascular Systems

Treating oxidative stress in heart failure: past, present and future

Atze van der Pol et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Review Cardiac & Cardiovascular Systems

Mechanisms of physiological and pathological cardiac hypertrophy

Michinari Nakamura et al.

NATURE REVIEWS CARDIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Targeting Transmembrane BAX Inhibitor Motif Containing 1 Alleviates Pathological Cardiac Hypertrophy

Ke-Qiong Deng et al.

CIRCULATION (2018)

Article Biochemistry & Molecular Biology

TRIM16 controls assembly and degradation of protein aggregates by modulating the p62-NRF2 axis and autophagy

Kautilya Kumar Jena et al.

EMBO JOURNAL (2018)

Editorial Material Cardiac & Cardiovascular Systems

Metabolic control and oxidative stress in pathological cardiac remodelling

Gabriele G. Schiattarella et al.

EUROPEAN HEART JOURNAL (2017)

Article Biochemistry & Molecular Biology

TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels

Ankush Borlepawar et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

Article Cardiac & Cardiovascular Systems

Bone Marrow-Derived Tenascin-C Attenuates Cardiac Hypertrophy by Controlling Inflammation

Lei Song et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Medicine, Research & Experimental

Tripartite motif 32 prevents pathological cardiac hypertrophy

Lijuan Chen et al.

CLINICAL SCIENCE (2016)

Article Biochemistry & Molecular Biology

The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy

Zhihua Wang et al.

NATURE MEDICINE (2016)

Article Multidisciplinary Sciences

The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling

Yan-Xiao Ji et al.

NATURE COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

Suppressor of IKKε is an essential negative regulator of pathological cardiac hypertrophy

Ke-Qiong Deng et al.

NATURE COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription

Eri H. Kobayashi et al.

NATURE COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3

Vinodkumar B. Pillai et al.

NATURE COMMUNICATIONS (2015)

Article Cardiac & Cardiovascular Systems

Dickkopf-3 attenuates pressure overload-induced cardiac remodelling

Yan Zhang et al.

CARDIOVASCULAR RESEARCH (2014)

Article Cell Biology

Regulation of PRDX1 peroxidase activity by Pin1

Kai Ling Chu et al.

CELL CYCLE (2013)

Article Cardiac & Cardiovascular Systems

Pathological Ventricular Remodeling: Mechanisms: Part 1 of 2

Jana S. Burchfield et al.

CIRCULATION (2013)

Article Multidisciplinary Sciences

TRIM16 Acts as an E3 Ubiquitin Ligase and Can Heterodimerize with Other TRIM Family Members

Jessica L. Bell et al.

PLOS ONE (2012)

Article Cardiac & Cardiovascular Systems

LEOPARD-type SHP2 mutant Gln510Glu attenuates cardiomyocyte differentiation and promotes cardiac hypertrophy via dysregulation of Akt/GSK-3β/β-catenin signaling

Hidekazu Ishida et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)

Review Biochemical Research Methods

Identifying components of protein complexes in C. elegans using co-immunoprecipitation and mass spectrometry

James J. Moresco et al.

JOURNAL OF PROTEOMICS (2010)

Article Biochemistry & Molecular Biology

CIB1 is a regulator of pathological cardiac hypertrophy

Joerg Heineke et al.

NATURE MEDICINE (2010)

Article Cardiac & Cardiovascular Systems

Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis

Janka Kisucka et al.

CIRCULATION RESEARCH (2008)

Review Immunology

TRIM family proteins and their emerging roles in innate immunity

Keiko Ozato et al.

NATURE REVIEWS IMMUNOLOGY (2008)

Article Biochemical Research Methods

Proteomics exploration reveals that actin is a signaling target of the kinase Akt

Franck Vandermoere et al.

MOLECULAR & CELLULAR PROTEOMICS (2007)

Article Biochemistry & Molecular Biology

The estrogen-responsive B box protein:: a novel enhancer of interleukin-1β secretion

C. Munding et al.

CELL DEATH AND DIFFERENTIATION (2006)

Article Cardiac & Cardiovascular Systems

Myocardial injury modulates the innate immune system and changes myocardial sensitivity

Georg Baumgarten et al.

BASIC RESEARCH IN CARDIOLOGY (2006)

Article Biochemistry & Molecular Biology

Regulation of peroxiredoxin I activity by Cdc2-mediated phosphorylation

TS Chang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)